Molecular Study of Acinetobacter baumannii Isolates for Metallo- β-Lactamases and Extended-Spectrum- β-Lactamases Genes in Intensive Care Unit, Mansoura University Hospital, Egypt
- PMID: 28567057
- PMCID: PMC5439075
- DOI: 10.1155/2017/3925868
Molecular Study of Acinetobacter baumannii Isolates for Metallo- β-Lactamases and Extended-Spectrum- β-Lactamases Genes in Intensive Care Unit, Mansoura University Hospital, Egypt
Abstract
Acinetobacter baumannii (A. baumannii) has been known as a causative pathogen of hospital acquired infections. The aim of this study is to examine the presence of A. baumannii among clinical isolates from intensive care unit (ICU) in Mansoura University Hospital (MUH), its antibiotic resistance pattern, and prevalence of antibiotic resistance genes metallo-β-lactamases (MBLs) and extended-spectrum-β-lactamases (ESBLs) among A. baumannii isolates. A. baumannii was identified by colony morphology, API 20E, and confirmed by detecting the bla OXA-51-like carbapenemase gene by PCR. Phenotypic expression of MBLs resistance was demonstrated by Combined Disk Test (CDT) in 273 isolates (97.5%) and of ESBLs was demonstrated by double disc synergy method (DDST) in 6 isolates (2.1%). MBLs genes were positive in 266 isolates (95%) and ESBLs genes were positive in 8 isolates (2.9%). The most frequent genes of MBLs studied genes were IMP (95.7%) followed by SIM and GIM (47.1% and 42.9%; resp.). For ESBL genes, the most frequent gene was TEM (2.9%). From this study, we conclude that multidrug resistant (MDR) A. baumannii with MBLs activity was the most common isolate. Careful monitoring for the presence of MDR A. baumannii among hospitalized patients is recommended to avoid wide dissemination of antibiotic resistance.
References
-
- Noori M., Karimi A., Fallah F., et al. High prevalence of metallo-beta-lactamase producing Acinetobacter baumannii isolated from two hospitals of Tehran, Iran. Archives of Pediatric Infectious Diseases. 2014;2(3) doi: 10.5812/pedinfect.15439.e15439 - DOI
-
- Karageorgopoulos D. E., Kelesidis T., Kelesidis I., Falagas M. E. Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence. Journal of Antimicrobial Chemotherapy. 2008;62(1):45–55. doi: 10.1093/jac/dkn165. - DOI - PMC - PubMed
-
- Safari M., Saidijam M., Bahador A., Jafari R., Alikhani M. Y. High prevalence of multidrug resistance and metallo-beta-lactamase (MβL) producing Acinetobacter baumannii isolated from patients in ICU wards, Hamadan, Iran. Journal of Research in Health Sciences. 2013;13(2):162–167. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
